Dr. Marco Valgimigli and Dr. C. Michael Gibson Discuss: 15-month results of the MASTER DAPT trial August 29, 2022 Disclosures: TBA
Dr. Sripal Bangalore Presents: ISCHEMIA-CKD EXTEND – Clinical Outcomes at 5 years of Follow-up August 29, 2022 Disclosure: TBA
Dr. Joo-Yong Hahn and Dr. C. Michael Gibson Discuss: The FRAME-AMI trial – FFR vs. Angiography-guided PCI in AMI with multivessel disease August 28, 2022 Disclosure: TBA
Dr. David Newby and Dr. Yazan Daaboul Discuss: The PRE18FFIR Trial: Coronary Plaque Activity to Predict Recurrent Events August 28, 2022 Disclosure: TBA
Dr. Axel Bauer and Dr. C. Michael Gibson Discuss: eBRAVE-AF – Smartphone-based AF screening August 28, 2022 Disclosures: TBA
Dr. Renato Lopes Presents: APOLLO – Apixaban for prophylaxis of thromboembolic outcomes in COVID-19 August 28, 2022 Disclosure: TBA
Dr. Mike Sharma and Dr. C. Michael Gibson Discuss: AXIOMATIC-SSP: Antithrombotic treatment with factor XIa inhibition to Optimize Management of Acute Thromboembolic events for Secondary Stroke Prevention August 28, 2022 Disclosures: TBA
Dr. Ashkan Shoamanesh and Dr. C. Michael Gibson Discuss: PACIFIC-STROKE – Phase 2 Program of AntiCoagulation via Inhibition of FXIa by the oral Compound BAY 2433334 – non-cardioembolic STROKE study August 28, 2022 Disclosure: TBA
Dr. John Alexander and Dr. C. Michael Gibson Discuss: PACIFIC-AMI – Efficacy and safety of factor XIa inhibitor asundexian on top of dual antiplatelet therapy after acute myocardial infarction August 28, 2022 Disclosure: TBA
